Book a demo
Presence & RecognitionEvent: September 8, 2026

CSNK2A1 Foundation released Episode 6 of Roadmap to Rare on Wednesday, September 9.

Published

Signal category

Presence & Recognition

Quote

Episode 6 of Roadmap to Rare drops Wednesday, September 9!

CSNK2A1 Foundation team

Company

CSNK2A1 Foundation

We are focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome.

Industry
Philanthropic Fundraising Services
Location
San Francisco, US
Company size
15 employees

CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives. CSNK2A1 Foundation is operated and funded through a committed team of volunteers, advocates and researchers. We aim to accomplish our mission by: * financing and encouraging meaningful research, * providing support to individuals affected and those that care for and love them, * promoting awareness, * educating patients, caregivers and health professionals and * advocating for issues important to our community. Okur-Chung Neurodevelopmental Syndrome is a rare genetic disorder first identified in 2016. OCNDS is caused by a mutation in the CSNK2A1 gene which is located on Chromosome 20. The gene CSNK2A1 creates a protein called CK2 which plays a crucial role in development. A mutation in this gene disrupts typical development. CSNK2A1 Foundation is a 501(c)(3) non-profit organization. EIN #82-4220939

Founded 2018

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.